A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies

INTRODUCTION: As Parkinson's disease (PD) progresses, the number/frequency of PD medications tend to increase, which is correlated with decreased patient compliance and suboptimal control of PD symptoms. We investigated efficacy and safety of levodopa-carbidopa intestinal gel (LCIG) daytime mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyd, James T., Zadikoff, Cindy, Benesh, Janet A., Zamudio, Jorge, Robieson, Weining Z., Kukreja, Pavnit, Yokoyama, Masayuki, Siddiqui, Mustafa S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302193/
https://www.ncbi.nlm.nih.gov/pubmed/34316616
http://dx.doi.org/10.1016/j.prdoa.2019.12.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302193/
https://www.ncbi.nlm.nih.gov/pubmed/34316616
http://dx.doi.org/10.1016/j.prdoa.2019.12.001

Ejemplares similares